BIO member Pfizer announced a new initiative to support biotechnology innovation, by investing in promising clinical-stage biotech companies.
The Pfizer Breakthrough Growth Initiative was established to ensure continuity of the most promising clinical development programs by investing up to $500 million in biotech companies and providing them with access to Pfizer’s scientific, clinical, and manufacturing expertise.
The initiative will focus on making non-controlling equity investments in clinical-stage public companies, primarily small- and medium-sized market capitalizations in categories including internal medicine, inflammation and immunology, oncology, rare disease, vaccines, and hospital.
Partner companies may also have the opportunity to access Pfizer’s expertise and resources in research, clinical development, and manufacturing.
And they’re looking globally, planning to collaborate with companies that have promising scientific breakthroughs, regardless of where they’re located.
What they’re saying: “We recognize that the uncertainty in the financial markets has exacerbated the need for many companies in the biotech community to seek alternative funding sources in order to continue their clinical programs. The Pfizer Breakthrough Growth Initiative will allow us deploy Pfizer’s resources to companies that share in our commitment to deliver transformative therapies to patients,” said John Young, Pfizer’s Chief Business Officer.
Interested? Contact pbgi@pfizer.com.
Want to know more about what Pfizer’s doing? Pfizer’s John Young will join us for a fireside chat during BIO Digital next Wednesday—register now!
More Health Care News:
Biopharma Dive: Eli Lilly starts first-ever trial of a COVID-19 antibody drug, speeding past rivals
“The antibody known as LY-CoV555, is being studied in a placebo-controlled Phase I trial in patients hospitalized with COVID-19, with results expected by the end of June.”
CBS News: Congo is battling coronavirus, measles and a new Ebola outbreak
“Health officials have confirmed a second Ebola outbreak in Congo, the World Health Organization said Monday.”